Multi-Omics Perspective Reveals the Different Patterns of Tumor Immune Microenvironment Based on Programmed Death Ligand 1 (PD-L1) Expression and Predictor of Responses to Immune Checkpoint Blockade across Pan-Cancer

Immune checkpoint inhibitor (ICI) therapies have shown great promise in cancer treatment. However, the intra-heterogeneity is a major barrier to reasonably classifying the potential benefited patients. Comprehensive heterogeneity analysis is needed to solve these clinical issues. In this study, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Kaitang, Hu, Meiling, Chen, Jiayun, Wei, Jinfen, Qin, Jingxin, Lin, Shudai, Du, Hongli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153013/
https://www.ncbi.nlm.nih.gov/pubmed/34068143
http://dx.doi.org/10.3390/ijms22105158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153013/
https://www.ncbi.nlm.nih.gov/pubmed/34068143
http://dx.doi.org/10.3390/ijms22105158

Ejemplares similares